İbrutinib Sonrası Gelişen Dev Ekimoz ve Hematom: Olgu Sunumu
Kronik lenfositik lösemi ve Mantle hücreli lenfoma da yeni bir tedavi seçeneği olan ibrutinib, yüksek etkinliği ile günümüzde sık kullanılmaya başlanmıştır. Hedefe yönelik monoklonal antikorların yan etkileri sitotoksik tedavilere göre daha hafif seviyede görülmektedir. İbrutinibin de ishal, bitkinl...
Saved in:
| Main Authors: | Aynur Uğur Bilgin, Özcan Çeneli, Handan Çipil, Sinan Demircioğlu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Selcuk University Press
2017-03-01
|
| Series: | Genel Tıp Dergisi |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2156683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
by: Justin T Low, et al.
Published: (2020-03-01) -
Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
by: Anna R. Bopp, et al.
Published: (2025-05-01) -
Drug review: Ibrutinib
by: Parathan Karunakaran
Published: (2020-01-01) -
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study
by: Noelia Pérez-Gómez, et al.
Published: (2025-07-01) -
Approaches to the prevention and therapy of ibrutinib-associated bleeding in adult patients
by: E. V. Volchkov, et al.
Published: (2018-10-01)